Citalopram Hydrobromide | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Citalopram Hydrobromide
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Citalopram Hydrobromide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

43 API Suppliers, 28 USDMF, 14 CEP/COS, 13 EU WC, 16 NDC API, 21 Listed Suppliers, $ API Reference Price

43 API Suppliers
28 USDMF
14 CEP/COS
13 EU WC
16 NDC API
21 Listed Suppliers
$ API Reference Price

INTERMEDIATES

6 Intermediate Suppliers

6 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

215 FDF Dossiers, 95 FDA Orange Book, 40 Europe, 55 Canada, 8 South Africa, 17 Listed Dossiers

215 FDF Dossiers
95 FDA Orange Book
40 Europe
55 Canada
8 South Africa
17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 20MG BASE, TABLET;ORAL - EQ 40MG BASE

TABLET;ORAL - EQ 10MG BASE
TABLET;ORAL - EQ 20MG BASE
TABLET;ORAL - EQ 40MG BASE

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Rochem International Inc, 18 SPI Pharma, 2 Seqens, 8 DKSH, 7 Faran Shimi Pharmaceutical, 11 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 33 BASF, 2 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 12 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 33 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 5 Novo Excipients, 4 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 29 Roquette, 13 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

96 Fillers, Diluents & Binders, 56 Coating Systems & Additives, 43 Disintegrants & Superdisintegrants, 40 Direct Compression, 32 Controlled & Modified Release, 32 Solubilizers, 31 Granulation, 30 Thickeners and Stabilizers, 27 Film Formers & Plasticizers, 25 Parenteral, 22 Taste Masking, 20 Topical, 19 Chewable & Orodispersible Aids, 17 Lubricants & Glidants, 17 Co-Processed Excipients, 9 Empty Capsules, 9 Emulsifying Agents, 7 API Stability Enhancers, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules, 1 Soft Gelatin

96 Fillers, Diluents & Binders
56 Coating Systems & Additives
43 Disintegrants & Superdisintegrants
40 Direct Compression
32 Controlled & Modified Release
32 Solubilizers
31 Granulation
30 Thickeners and Stabilizers
27 Film Formers & Plasticizers
25 Parenteral
22 Taste Masking
20 Topical
19 Chewable & Orodispersible Aids
17 Lubricants & Glidants
17 Co-Processed Excipients
9 Empty Capsules
9 Emulsifying Agents
7 API Stability Enhancers
5 Surfactant & Foaming Agents
5 Coloring Agents
5 Rheology Modifiers
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 2 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
2 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 15 Finished Drug Prices

2 US Medicaid Prescriptions
15 Finished Drug Prices

MARKET PLACE

2 APIs

2 APIs

PATENTS & EXCLUSIVITIES

6 Health Canada Patents

6 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 1 Others

3 EDQM
1 USP
1 Others

$ API Ref.Price (USD/KG) : 168 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 6Lundbeck Canada Inc.

filter Patent Reset all filters

6 All

01 32049368

02 32353693

filter Product Reset all filters

6 All

01 6Citalopram Hydrobromide

filter Dosage Reset all filters

6 All

01 6Tablet

filter Exp Date Reset all filters

6 All

01 32011-08-16

02 32021-07-24

Product Main Page

01

Lundbeck Canada Inc.

Citalopram Hydrobromide

PharmScience R&D

Not Confirmed

Lundbeck Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-07-24

Date Granted : 2003-07-22

Citalopram Hydrobromide

Brand Name : CELEXA

Patent Number : 2353693

Filing Date : 2001-07-24

Strength per Unit : 10 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2021-07-24

Date Granted : 2003-07-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Lundbeck Canada Inc.

Citalopram Hydrobromide

PharmScience R&D

Not Confirmed

Lundbeck Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-07-24

Date Granted : 2003-07-22

Citalopram Hydrobromide

Brand Name : CELEXA

Patent Number : 2353693

Filing Date : 2001-07-24

Strength per Unit : 20 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2021-07-24

Date Granted : 2003-07-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Lundbeck Canada Inc.

Citalopram Hydrobromide

PharmScience R&D

Not Confirmed

Lundbeck Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-07-24

Date Granted : 2003-07-22

Citalopram Hydrobromide

Brand Name : CELEXA

Patent Number : 2353693

Filing Date : 2001-07-24

Strength per Unit : 40 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2021-07-24

Date Granted : 2003-07-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Lundbeck Canada Inc.

Citalopram Hydrobromide

PharmScience R&D

Not Confirmed

Lundbeck Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-08-16

Date Granted : 2001-10-23

Citalopram Hydrobromide

Brand Name : CELEXA

Patent Number : 2049368

Filing Date : 1991-08-16

Strength per Unit : 10 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-08-16

Date Granted : 2001-10-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Lundbeck Canada Inc.

Citalopram Hydrobromide

PharmScience R&D

Not Confirmed

Lundbeck Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-08-16

Date Granted : 2001-10-23

Citalopram Hydrobromide

Brand Name : CELEXA

Patent Number : 2049368

Filing Date : 1991-08-16

Strength per Unit : 20 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-08-16

Date Granted : 2001-10-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Lundbeck Canada Inc.

Citalopram Hydrobromide

PharmScience R&D

Not Confirmed

Lundbeck Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-08-16

Date Granted : 2001-10-23

Citalopram Hydrobromide

Brand Name : CELEXA

Patent Number : 2049368

Filing Date : 1991-08-16

Strength per Unit : 40 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-08-16

Date Granted : 2001-10-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!